PIER 88 INVESTMENT PARTNERS LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1697366
SAN FRANCISCO, CA
Position in HALO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,227,970
-$69,574 QoQ
Shares Held
19,000
-1.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PIER 88 INVESTMENT PARTNERS LLC holds $8,185,124 across 11 Biotechnology names. HALO ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
8,000 | $1,597,200 | |
| 2 | DNLI |
Denali Therapeutics Inc.
|
64,800 | $1,244,160 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
19,000 | $1,227,970 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
3,500 | $904,120 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,200 | $628,164 | |
| 6 | ABSI |
Absci Corp
|
206,100 | $618,300 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
7,700 | $571,802 | |
| 8 | INSM |
INSMED Inc
|
3,200 | $523,264 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,227,970 | 19,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,297,544 | 19,280 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,471,200 | 20,060 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $547,250 | 10,520 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $507,289 | 7,950 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||